vimarsana.com
Home
Live Updates
Genomic Vision announces the issuance of the 2nd tranche of
Genomic Vision announces the issuance of the 2nd tranche of
Genomic Vision announces the issuance of the 2nd tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million
Regulatory News: Genomic Vision (the "Company" FR0011799907 GV) (Paris:GV), a biotechnology company that develops products and services for the highly accurate characterization of DNA sequences
Related Keywords
Paris ,
France General ,
France ,
Bagneux ,
Dennis Riedl ,
Aaron Bensimon ,
Strategic Communications ,
Euronext ,
Genomic Vision The Company ,
Regulatory News ,
Genomic Vision ,
Executive Board ,
Des Meuniers ,
Genomic ,
Vision ,
Nnounces ,
Issuance ,
Tranche ,
Convertible ,
Votes ,
Warrants ,
Ocabsa ,
Billion ,
Art ,
Financing ,
Line ,
Oncluded ,
Inance ,
Maximum ,
Amount ,